- Home
- NYAX vs CNTA Comparison
NYAX vs CNTA Comparison
Compare NYAX & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYAX
- CNTA
- Stock Information
- Founded
- NYAX 2005
- CNTA 2020
- Country
- NYAX Israel
- CNTA United Kingdom
- Employees
- NYAX N/A
- CNTA 86
- Industry
- NYAX
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- NYAX
- CNTA Health Care
- Exchange
- NYAX Nasdaq
- CNTA Nasdaq
- Market Cap
- NYAX 1.5B
- CNTA 1.6B
- IPO Year
- NYAX N/A
- CNTA 2021
- Fundamental
- Price
- NYAX $47.36
- CNTA $12.43
- Analyst Decision
- NYAX Buy
- CNTA Strong Buy
- Analyst Count
- NYAX 6
- CNTA 11
- Target Price
- NYAX $38.33
- CNTA $27.00
- AVG Volume (30 Days)
- NYAX 22.7K
- CNTA 1.2M
- Earning Date
- NYAX 08-06-2025
- CNTA 08-12-2025
- Dividend Yield
- NYAX N/A
- CNTA N/A
- EPS Growth
- NYAX N/A
- CNTA N/A
- EPS
- NYAX 0.18
- CNTA N/A
- Revenue
- NYAX $331,161,000.00
- CNTA $15,000,000.00
- Revenue This Year
- NYAX $33.44
- CNTA N/A
- Revenue Next Year
- NYAX $23.74
- CNTA N/A
- P/E Ratio
- NYAX $265.91
- CNTA N/A
- Revenue Growth
- NYAX 34.05
- CNTA 118.88
- 52 Week Low
- NYAX $20.31
- CNTA $8.46
- 52 Week High
- NYAX $47.37
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- NYAX 63.68
- CNTA 47.36
- Support Level
- NYAX $42.40
- CNTA $11.77
- Resistance Level
- NYAX $45.60
- CNTA $13.06
- Average True Range (ATR)
- NYAX 1.03
- CNTA 0.70
- MACD
- NYAX 0.07
- CNTA 0.03
- Stochastic Oscillator
- NYAX 100.00
- CNTA 51.21
About NYAX Nayax Ltd.
Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.